Molecular Partners AG
MLLCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $8 | $0 | $0 | $0 |
| Gross Profit | -$8 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $8 | $11 | $12 | $11 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4 | $4 | $4 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $3 | $0 | $0 |
| Operating Expenses | $12 | $17 | $16 | $15 |
| Operating Income | -$12 | -$17 | -$16 | -$15 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | -$3 | -$1 | $4 |
| Pre-Tax Income | -$12 | -$20 | -$17 | -$11 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | -$12 | -$20 | -$17 | -$11 |
| % Margin | – | – | – | – |
| EPS | -0.32 | -0.56 | -0.45 | -0.34 |
| % Growth | 42.9% | -24.4% | -32.4% | – |
| EPS Diluted | -0.32 | -0.56 | -0.45 | -0.34 |
| Weighted Avg Shares Out | 37 | 37 | 37 | 33 |
| Weighted Avg Shares Out Dil | 37 | 37 | 37 | 33 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$11 | -$20 | -$16 | -$11 |
| % Margin | – | – | – | – |